| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atherosclerosis & Lipoproteins |
From the Institute of Biochemistry (J.B., P.C., H.S., C.G., R.J.K., H.K.) and the Laboratory of Functional Genome Research (R.J.K.), University Clinics Charité, Humboldt University, Berlin, Germany; and the Departments of Pharmacology (T.Y.), Kanazawa University School of Medicine, Japan.
Correspondence to Dr Hartmut Kuhn, Institute of Biochemistry, University Clinics Charité, Humboldt University, Monbijoustr. 2, 10117 Berlin, Germany. E-mail hartmut.kuehn{at}charite.de
Objectives Lipoxygenases with different positional specificity have been implicated in atherogenesis, but the precise roles of the various isoforms remain unclear. Because of its capability of oxidizing low-density lipoprotein (LDL) to an atherogenic form, 12/15-lipoxygenases have been suggested to initiate LDL oxidation in vivo; thus, these enzymes may exhibit pro-atherogenic activities. However, in several rabbit atherosclerosis models, the enzyme appears to act atheroprotective.
Methods and Results To test the impact of 12/15-lipoxygenase expression on early atherogenesis, we established an in vitro foam cell model, which is based on the uptake of acetylated LDL by murine macrophages. In this system, we found that 12/15-lipoxygenase expression protects the cells from intracellular lipid deposition. This effect was related to an attenuated uptake of modified LDL, as indicated by impaired expression of scavenger receptor A and to accelerated intracellular lipid metabolism.
Conclusions Our results indicate that the role of 12/15-lipoxygenase in atherogenesis may not be restricted to oxidative LDL modification. Expression of this lipid-peroxidizing enzyme may impact both lipid uptake and intracellular lipid turnover. These data provide a plausible explanation for the antiatherogenic effect of 12/15-LOX in rabbit atherosclerosis models.
Lipoxygenases have been implicated in atherogenesis but their precise roles remain unclear. We tested the impact of 12/15-lipoxygenase on in vitro foam cell formation and found that the enzyme protected macrophages from intracellular lipid deposition. This effect was related to impaired scavenger receptor A expression and to accelerated lipid metabolism.
Key Words: atherogenesis eicosanoids gene expression inflammation microarrays
This article has been cited by other articles:
![]() |
M. H. Nagelin, S. Srinivasan, J. L. Nadler, and C. C. Hedrick Murine 12/15-Lipoxygenase Regulates ATP-binding Cassette Transporter G1 Protein Degradation through p38- and JNK2-dependent Pathways J. Biol. Chem., November 6, 2009; 284(45): 31303 - 31314. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Weibel, M. R. Joshi, E. T. Alexander, P. Zhu, I. A. Blair, and G. H. Rothblat Overexpression of Human 15(S)-Lipoxygenase-1 in RAW Macrophages Leads to Increased Cholesterol Mobilization and Reverse Cholesterol Transport Arterioscler Thromb Vasc Biol, June 1, 2009; 29(6): 837 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Nagelin, S. Srinivasan, J. Lee, J. L. Nadler, and C. C. Hedrick 12/15-Lipoxygenase Activity Increases the Degradation of Macrophage ATP-Binding Cassette Transporter G1 Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1811 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Daugherty, N. R. Webb, D. L. Rateri, and V. L. King Thematic review series: The Immune System and Atherogenesis. Cytokine regulation of macrophage functions in atherogenesis J. Lipid Res., September 1, 2005; 46(9): 1812 - 1822. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |